INFUDOPA Trademark

Trademark Overview

On Tuesday, September 11, 2018, a trademark application was filed for INFUDOPA with the United States Patent and Trademark Office. The USPTO has given the INFUDOPA trademark a serial number of 79243156. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2019. This trademark is owned by Dizlin Pharmaceuticals AB. The INFUDOPA trademark is filed in the Pharmaceutical Products category with the following description:

Pharmaceutical preparations for treating diseases of the central nervous system
infudopa

General Information

Serial Number79243156
Word MarkINFUDOPA
Filing DateTuesday, September 11, 2018
Status700 - REGISTERED
Status DateTuesday, July 2, 2019
Registration Number5790782
Registration DateTuesday, July 2, 2019
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 16, 2019

Trademark Statements

Goods and ServicesPharmaceutical preparations for treating diseases of the central nervous system

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, October 19, 2018
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameDizlin Pharmaceuticals AB
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSE
Party NameDizlin Pharmaceuticals AB
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSE
Party NameDizlin Pharmaceuticals AB
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSE

Trademark Events

Event DateEvent Description
Thursday, December 20, 2018ASSIGNED TO EXAMINER
Thursday, October 18, 2018SN ASSIGNED FOR SECT 66A APPL FROM IB
Friday, October 19, 2018NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Tuesday, October 23, 2018APPLICATION FILING RECEIPT MAILED
Friday, December 21, 2018NON-FINAL ACTION WRITTEN
Saturday, December 22, 2018NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Friday, January 11, 2019REFUSAL PROCESSED BY MPU
Friday, January 11, 2019NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Saturday, February 2, 2019REFUSAL PROCESSED BY IB
Thursday, February 7, 2019TEAS RESPONSE TO OFFICE ACTION RECEIVED
Thursday, February 7, 2019CORRESPONDENCE RECEIVED IN LAW OFFICE
Thursday, February 7, 2019TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, February 21, 2019APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, March 27, 2019NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, April 16, 2019PUBLISHED FOR OPPOSITION
Tuesday, April 16, 2019OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 2, 2019REGISTERED-PRINCIPAL REGISTER
Wednesday, October 2, 2019FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Wednesday, October 23, 2019FINAL DISPOSITION NOTICE SENT TO IB
Friday, November 8, 2019FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, July 2, 2024COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
Wednesday, October 23, 2019FINAL DISPOSITION PROCESSED
Thursday, February 20, 2020CHANGE OF NAME/ADDRESS REC'D FROM IB

Related Keywords

infudopa nervous system central diseases preparations treating pharmaceutical